104 related articles for article (PubMed ID: 25417756)
1. Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohorts.
Ziouèche-Mottet A; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Belichard C; Faure C; Chéreau Ewald E; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Tallet A; Bannier M; Minsat M; Lambaudie E; Resbeut M
BMC Cancer; 2014 Nov; 14():868. PubMed ID: 25417756
[TBL] [Abstract][Full Text] [Related]
2. Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survival.
Lambaudie E; Houvenaeghel G; Ziouèche A; Knight S; Dravet F; Garbay JR; Giard S; Charitansky H; Cohen M; Faure C; Hudry D; Azuar P; Villet R; Gimbergues P; de Lara CT; Tallet A; Bannier M; Minsat M; Resbeut M
BMC Surg; 2016 Nov; 16(1):74. PubMed ID: 27846840
[TBL] [Abstract][Full Text] [Related]
3. A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer.
Sperk E; Astor D; Keller A; Welzel G; Gerhardt A; Tuschy B; Sütterlin M; Wenz F
Radiat Oncol; 2014 Jul; 9():154. PubMed ID: 25015740
[TBL] [Abstract][Full Text] [Related]
4. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
[TBL] [Abstract][Full Text] [Related]
5. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.
Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Keshtgar M; Flyger HL; Massarut S; Alvarado M; Saunders C; Eiermann W; Metaxas M; Sperk E; Sütterlin M; Brown D; Esserman L; Roncadin M; Thompson A; Dewar JA; Holtveg HM; Pigorsch S; Falzon M; Harris E; Matthews A; Brew-Graves C; Potyka I; Corica T; Williams NR; Baum M;
Lancet; 2014 Feb; 383(9917):603-13. PubMed ID: 24224997
[TBL] [Abstract][Full Text] [Related]
6. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost.
Vaidya JS; Baum M; Tobias JS; Massarut S; Wenz F; Murphy O; Hilaris B; Houghton J; Saunders C; Corica T; Roncadin M; Kraus-Tiefenbacher U; Melchaert F; Keshtgar M; Sainsbury R; Douek M; Harrison E; Thompson A; Joseph D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1335-8. PubMed ID: 17084562
[TBL] [Abstract][Full Text] [Related]
7. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
[TBL] [Abstract][Full Text] [Related]
8. Postmastectomy radiation and recurrence patterns in breast cancer patients younger than age 35 years: a population-based cohort.
Quan ML; Osman F; McCready D; Fernandes K; Sutradhar R; Paszat L
Ann Surg Oncol; 2014 Feb; 21(2):395-400. PubMed ID: 24145994
[TBL] [Abstract][Full Text] [Related]
9. Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT.
Coombs NJ; Coombs JM; Vaidya UJ; Singer J; Bulsara M; Tobias JS; Wenz F; Joseph DJ; Brown DA; Rainsbury R; Davidson T; Adamson DJ; Massarut S; Morgan D; Potyka I; Corica T; Falzon M; Williams N; Baum M; Vaidya JS
BMJ Open; 2016 May; 6(5):e010703. PubMed ID: 27160842
[TBL] [Abstract][Full Text] [Related]
10. Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effects.
Sedlmayer F; Zehentmayr F; Fastner G
Breast; 2013 Aug; 22 Suppl 2():S141-6. PubMed ID: 24074775
[TBL] [Abstract][Full Text] [Related]
11. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group.
Hannoun-Levi JM; Resch A; Gal J; Kauer-Dorner D; Strnad V; Niehoff P; Loessl K; Kovács G; Van Limbergen E; Polgár C;
Radiother Oncol; 2013 Aug; 108(2):226-31. PubMed ID: 23647758
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 2--TARGIT.
Silverstein MJ; Fastner G; Maluta S; Reitsamer R; Goer DA; Vicini F; Wazer D
Ann Surg Oncol; 2014 Nov; 21(12):3793-9. PubMed ID: 25138079
[TBL] [Abstract][Full Text] [Related]
13. Prognosis after breast recurrence following conservative surgery and radiotherapy in patients with node-negative breast cancer.
Francis M; Cakir B; Ung O; Gebski V; Boyages J
Br J Surg; 1999 Dec; 86(12):1556-62. PubMed ID: 10594505
[TBL] [Abstract][Full Text] [Related]
14. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
[TBL] [Abstract][Full Text] [Related]
15. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
[TBL] [Abstract][Full Text] [Related]
16. Targeted Intraoperative Radiotherapy Is Non-inferior to Conventional External Beam Radiotherapy in Chinese Patients With Breast Cancer: A Propensity Score Matching Study.
Mi Y; Lv P; Wang F; Li L; Zhu M; Wang Y; Zhang Y; Liu L; Cao Q; Dong M; Shi Y; Fan R; Li J; Gu Y; Zuo X
Front Oncol; 2020; 10():550327. PubMed ID: 33134162
[No Abstract] [Full Text] [Related]
17. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results].
Fodor J; Sulyok Z; Polgár C; Major T; Tóth J; Németh G
Magy Seb; 2001 Aug; 54(4):209-14. PubMed ID: 11550486
[TBL] [Abstract][Full Text] [Related]
18. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).
Holmes DR; Baum M; Joseph D
Am J Surg; 2007 Oct; 194(4):507-10. PubMed ID: 17826067
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results.
Patel RR; Christensen ME; Hodge CW; Adkison JB; Das RK
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):970-3. PubMed ID: 18313521
[TBL] [Abstract][Full Text] [Related]
20. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
